Clinical trials in diabetic populations reveal that L-Carnitine supplementation significantly improves glycemic control markers
Review the injection site reaction guide for detailed management advice
GLP-1 receptor agonists may offer a new approach that can complement existing topical, systemic and biologic treatment options. Across the trials, clinicians treated participants with one of three GLP-1s 81.5% received semaglutide (Wegovy, Novo Nordisk), 17.4% received liraglutide and 1% received tirzepatide (Zepbound, Eli Lilly) at varying dosages and treatment durations
During this session, your provider will assess your skins texture, elasticity, and areas of concern, discuss your aesthetic goals and medical history, explain the XERF treatment process in detail, and recommend a personalized treatment plan including the number of sessions that may be appropriate for your goals